Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding.

Dube D, Brecher MB, Delos SE, Rose SC, Park EW, Schornberg KL, Kuhn JH, White JM.

J Virol. 2009 Apr;83(7):2883-91. doi: 10.1128/JVI.01956-08. Epub 2009 Jan 14.

2.

Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion.

Bale S, Liu T, Li S, Wang Y, Abelson D, Fusco M, Woods VL Jr, Saphire EO.

PLoS Negl Trop Dis. 2011 Nov;5(11):e1395. doi: 10.1371/journal.pntd.0001395. Epub 2011 Nov 15.

3.

Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2.

Gregory SM, Harada E, Liang B, Delos SE, White JM, Tamm LK.

Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11211-6. doi: 10.1073/pnas.1104760108. Epub 2011 Jun 20.

4.

Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry.

Dube D, Schornberg KL, Shoemaker CJ, Delos SE, Stantchev TS, Clouse KA, Broder CC, White JM.

Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16637-42. doi: 10.1073/pnas.1008509107. Epub 2010 Sep 3.

5.

Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.

Lennemann NJ, Rhein BA, Ndungo E, Chandran K, Qiu X, Maury W.

MBio. 2014 Jan 28;5(1):e00862-13. doi: 10.1128/mBio.00862-13.

6.

Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry.

Wang J, Manicassamy B, Caffrey M, Rong L.

Virol Sin. 2011 Jun;26(3):156-70. doi: 10.1007/s12250-011-3194-9. Epub 2011 Jun 12.

PMID:
21667336
7.

Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Watanabe S, Takada A, Watanabe T, Ito H, Kida H, Kawaoka Y.

J Virol. 2000 Nov;74(21):10194-201.

8.

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

Martinez O, Ndungo E, Tantral L, Miller EH, Leung LW, Chandran K, Basler CF.

J Virol. 2013 Mar;87(6):3324-34. doi: 10.1128/JVI.01598-12. Epub 2013 Jan 9.

9.

Comprehensive analysis of ebola virus GP1 in viral entry.

Manicassamy B, Wang J, Jiang H, Rong L.

J Virol. 2005 Apr;79(8):4793-805.

10.

A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Wong AC, Sandesara RG, Mulherkar N, Whelan SP, Chandran K.

J Virol. 2010 Jan;84(1):163-75. doi: 10.1128/JVI.01832-09. Epub .

11.

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.

Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO.

Nature. 2008 Jul 10;454(7201):177-82. doi: 10.1038/nature07082.

12.

Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger.

Markosyan RM, Miao C, Zheng YM, Melikyan GB, Liu SL, Cohen FS.

PLoS Pathog. 2016 Jan 5;12(1):e1005373. doi: 10.1371/journal.ppat.1005373. eCollection 2016 Jan.

13.

Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.

Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.

J Virol. 2011 Sep;85(17):8502-13. doi: 10.1128/JVI.02600-10. Epub 2011 Jun 22.

14.

Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.

Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J.

Nature. 2011 Aug 24;477(7364):344-8. doi: 10.1038/nature10380.

15.

Filovirus entry: a novelty in the viral fusion world.

Hunt CL, Lennemann NJ, Maury W.

Viruses. 2012 Feb;4(2):258-75. doi: 10.3390/v4020258. Epub 2012 Feb 7. Review.

16.

Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein.

Lee JE, Fusco ML, Abelson DM, Hessell AJ, Burton DR, Saphire EO.

Acta Crystallogr D Biol Crystallogr. 2009 Nov;65(Pt 11):1162-80. doi: 10.1107/S0907444909032314. Epub 2009 Oct 22.

17.

Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.

Hood CL, Abraham J, Boyington JC, Leung K, Kwong PD, Nabel GJ.

J Virol. 2010 Mar;84(6):2972-82. doi: 10.1128/JVI.02151-09. Epub 2010 Jan 6.

18.

Expression of Ebolavirus glycoprotein on the target cells enhances viral entry.

Manicassamy B, Rong L.

Virol J. 2009 Jun 8;6:75. doi: 10.1186/1743-422X-6-75.

19.

Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.

Becquart P, Mahlakõiv T, Nkoghe D, Leroy EM.

PLoS One. 2014 Jun 10;9(6):e96360. doi: 10.1371/journal.pone.0096360. eCollection 2014.

20.

Identification of a small-molecule entry inhibitor for filoviruses.

Basu A, Li B, Mills DM, Panchal RG, Cardinale SC, Butler MM, Peet NP, Majgier-Baranowska H, Williams JD, Patel I, Moir DT, Bavari S, Ray R, Farzan MR, Rong L, Bowlin TL.

J Virol. 2011 Apr;85(7):3106-19. doi: 10.1128/JVI.01456-10. Epub 2011 Jan 26.

Items per page

Supplemental Content

Write to the Help Desk